Claris Biotherapeutics, Inc. — Form D

Claris Biotherapeutics, Inc. of HALF MOON BAY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-22. The offering totals $2.3M, of which $2.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Clarke AtwellDirectorHalf Moon Bay, CA
Reza DanaDirectorHalf Moon Bay, CA
Marc de GaridelDirectorHalf Moon Bay, CA
Meredith FisherDirectorHalf Moon Bay, CA
Kenneth HarrisonDirectorHalf Moon Bay, CA
Clarke AtwellExecutive OfficerHalf Moon Bay, CA
Susan OrrExecutive OfficerHalf Moon Bay, CA
Henry RathExecutive OfficerHalf Moon Bay, CA
Reza DanaRelated PersonHalf Moon Bay, CA
Michael DybbsRelated PersonHalf Moon Bay, CA
Meredith FisherRelated PersonHalf Moon Bay, CA
Kenneth HarrisonRelated PersonHalf Moon Bay, CA
Henry RathRelated PersonHalf Moon Bay, CA
Susan OrrRelated PersonHalf Moon Bay, CA
Clarke AtwellRelated PersonHalf Moon Bay, CA
Marc de GaridelRelated PersonHalf Moon Bay, CA
Brian BaumRelated PersonHalf Moon Bay, CA
Marc Clarke de GaridelDirectorJersey City, NJ
Anton Clarke AtwellDirectorJersey City, NJ
Anton Clarke AtwellExecutive OfficerJersey City, NJ
Meredith Clarke FisherDirectorJersey City, NJ
Kenneth Clarke HarrisonDirectorJersey City, NJ
Reza Clarke DanaDirectorJersey City, NJ
Maha RadhakrishnanRelated PersonHalf Moon Bay, CA
Stephen BradyRelated PersonHalf Moon Bay, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2026-08-07D$121.5M$55.7M
2025-03-07D$3.3M$3.3M
2024-01-08D$10.0M$10.0M
2023-10-24D/A$44.5M$44.5M
2021-07-14D/A$38.5M$38.5M
2020-04-27D$26.0M$11.8M

More